we are confident in our ability to continue executing well in the face of covid uncertainties and are raising our full-year guidance for organic growth to num-one% to num-two%, and earnings per share to $num-three to $num-four.
we now anticipate earnings of $num-one to $num-two per share against a prior range of $num-three to $num-one.
we are confident in our ability to continue executing well in the face of covid uncertainties and are raising our full-year guidance for organic growth to num-one% to num-two%, and earnings per share to $num-three to $num-four.
we now anticipate earnings of $num-one to $num-two per share against a prior range of $num-three to $num-one.
we posted organic growth of num-one% versus a num-two% decline in last year's second quarter, along with earnings of $num-three per share.
second-quarter gaap and adjusted earnings per share were $num-one, up num-two% compared to last year's adjusted results.